메뉴 건너뛰기




Volumn 44, Issue 6, 2004, Pages

Expanded-spectrum β-lactamase producing Klebsiella pneumoniae-related peritonitis in a patient on peritoneal dialysis

Author keywords

Continuous ambulatory peritoneal dialysis (CAPD); end stage renal disease (ESRD); expanded spectrum lactamase (ESBL); flomoxef; Klebsiella pneumoniae; peritonitis

Indexed keywords

BETA LACTAMASE; CEFTAZIDIME; FLOMOXEF;

EID: 9344263435     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.08.037     Document Type: Article
Times cited : (7)

References (24)
  • 2
    • 0033785676 scopus 로고    scopus 로고
    • International Society for Peritoneal Dialysis. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update
    • W.F. Keane, G.R. Bailie, E. Boeschoten International Society for Peritoneal Dialysis. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update Perit Dial Int 20 2000 396 411
    • (2000) Perit Dial Int , vol.20 , pp. 396-411
    • Keane, W.F.1    Bailie, G.R.2    Boeschoten, E.3
  • 3
    • 0034763241 scopus 로고    scopus 로고
    • Extended-spectrum beta-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat
    • P.A. Bradford Extended-spectrum beta-lactamases in the 21st century Characterization, epidemiology, and detection of this important resistance threat Clin Microbiol Rev 14 2001 933 951
    • (2001) Clin Microbiol Rev , vol.14 , pp. 933-951
    • Bradford, P.A.1
  • 4
    • 0037282428 scopus 로고    scopus 로고
    • Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: Considerations for diagnosis, prevention and drug treatment
    • M.E. Rupp, P.D. Fey Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae Considerations for diagnosis, prevention and drug treatment Drugs 63 2003 353 365
    • (2003) Drugs , vol.63 , pp. 353-365
    • Rupp, M.E.1    Fey, P.D.2
  • 5
    • 0026409956 scopus 로고
    • In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin)
    • A. Bauernfeind, S. Schweighart, E. Eberlein, R. Jungwirth In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin) Infection 19 Suppl 5 1991 264 275
    • (1991) Infection , vol.19 , Issue.5 , pp. 264-275
    • Bauernfeind, A.1    Schweighart, S.2    Eberlein, E.3    Jungwirth, R.4
  • 6
    • 0025274003 scopus 로고
    • Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases
    • G.A. Jacoby, I. Carreras Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases Antimicrob Agents Chemother 34 1990 858 862
    • (1990) Antimicrob Agents Chemother , vol.34 , pp. 858-862
    • Jacoby, G.A.1    Carreras, I.2
  • 8
    • 0035684366 scopus 로고    scopus 로고
    • Pulmonary infectious mortality among patients with end-stage renal disease
    • M.J. Sarnak, B.L. Jaber Pulmonary infectious mortality among patients with end-stage renal disease Chest 120 2001 1883 1887
    • (2001) Chest , vol.120 , pp. 1883-1887
    • Sarnak, M.J.1    Jaber, B.L.2
  • 9
    • 0033764426 scopus 로고    scopus 로고
    • Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998
    • S. Zelenitsky, L. Barns, I. Findlay Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998 Am J Kidney Dis 36 2000 1009 1013
    • (2000) Am J Kidney Dis , vol.36 , pp. 1009-1013
    • Zelenitsky, S.1    Barns, L.2    Findlay, I.3
  • 10
    • 0023181082 scopus 로고
    • Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae
    • C. Brun-Buisson, P. Legrand, A. Philippon, F. Montravers, M. Ansquer, J. Duval Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae Lancet 2 1987 302 306
    • (1987) Lancet , vol.2 , pp. 302-306
    • Brun-Buisson, C.1    Legrand, P.2    Philippon, A.3    Montravers, F.4    Ansquer, M.5    Duval, J.6
  • 11
    • 1942422567 scopus 로고    scopus 로고
    • The effects of peritoneal dialysis solutions on peritoneal host defense
    • S. Mortier, N.H. Lameire, A.S. De Vriese The effects of peritoneal dialysis solutions on peritoneal host defense Perit Dial Int 24 2004 123 138
    • (2004) Perit Dial Int , vol.24 , pp. 123-138
    • Mortier, S.1    Lameire, N.H.2    De Vriese, A.S.3
  • 12
    • 0034285477 scopus 로고    scopus 로고
    • Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)
    • D.L. Paterson Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) Clin Microbiol Infect 6 2000 460 463
    • (2000) Clin Microbiol Infect , vol.6 , pp. 460-463
    • Paterson, D.L.1
  • 13
    • 0028097155 scopus 로고
    • Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam
    • E.S. Go, C. Urban, J. Burns Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam Lancet 344 1994 1329 1332
    • (1994) Lancet , vol.344 , pp. 1329-1332
    • Go, E.S.1    Urban, C.2    Burns, J.3
  • 14
    • 0032517251 scopus 로고    scopus 로고
    • Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
    • J.J. Rahal, C. Urban, D. Horn Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella JAMA 280 1998 1233 1237
    • (1998) JAMA , vol.280 , pp. 1233-1237
    • Rahal, J.J.1    Urban, C.2    Horn, D.3
  • 15
    • 0033047527 scopus 로고    scopus 로고
    • The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen
    • S.C. Sanyal, E.M. Mokaddas The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen J Chemother 11 1999 28 33
    • (1999) J Chemother , vol.11 , pp. 28-33
    • Sanyal, S.C.1    Mokaddas, E.M.2
  • 16
    • 0035189967 scopus 로고    scopus 로고
    • Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae
    • K.S. Thomson, E.S. Moland Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae Antimicrob Agents Chemother 45 2001 3548 3554
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 3548-3554
    • Thomson, K.S.1    Moland, E.S.2
  • 17
    • 0034034589 scopus 로고    scopus 로고
    • Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia
    • D.L. Paterson, L. Mulazimoglu, J.M. Casellas Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia Clin Infect Dis 30 2000 473 478
    • (2000) Clin Infect Dis , vol.30 , pp. 473-478
    • Paterson, D.L.1    Mulazimoglu, L.2    Casellas, J.M.3
  • 18
    • 0026089266 scopus 로고
    • Properties of plasmids responsible for production of extended-spectrum β-lactamases
    • G.A. Jacoby, L. Sutton Properties of plasmids responsible for production of extended-spectrum β-lactamases Antimicrob Agents Chemother 35 1991 164 169
    • (1991) Antimicrob Agents Chemother , vol.35 , pp. 164-169
    • Jacoby, G.A.1    Sutton, L.2
  • 19
    • 0033998662 scopus 로고    scopus 로고
    • Biochemical sequence analyses of GES-1, a novel Class a extended-spectrum β-lactamase, and the Class 1 integron In52 from Klebsiella pneumoniae
    • L. Poirel, I. Le Thomas, T. Naas, A. Karim, P. Nordmann Biochemical sequence analyses of GES-1, a novel Class A extended-spectrum β-lactamase, and the Class 1 integron In52 from Klebsiella pneumoniae Antimicrob Agents Chemother 44 2000 622 632
    • (2000) Antimicrob Agents Chemother , vol.44 , pp. 622-632
    • Poirel, L.1    Le Thomas, I.2    Naas, T.3    Karim, A.4    Nordmann, P.5
  • 20
    • 0034088492 scopus 로고    scopus 로고
    • Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan
    • J.J. Yan, S.M. Wu, S.H. Tsai, J.J. Wu, I.J. Su Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan Antimicrob Agents Chemother 44 2000 1438 1442
    • (2000) Antimicrob Agents Chemother , vol.44 , pp. 1438-1442
    • Yan, J.J.1    Wu, S.M.2    Tsai, S.H.3    Wu, J.J.4    Su, I.J.5
  • 21
    • 0035003640 scopus 로고    scopus 로고
    • Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: Implications for the clinical microbiology laboratory
    • D.L. Paterson, W.C. Ko, A. Von Gottberg Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases Implications for the clinical microbiology laboratory J Clin Microbiol 39 2001 2206 2212
    • (2001) J Clin Microbiol , vol.39 , pp. 2206-2212
    • Paterson, D.L.1    Ko, W.C.2    Von Gottberg, A.3
  • 22
    • 0036780839 scopus 로고    scopus 로고
    • Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia
    • B.N. Kim, J.H. Woo, M.N. Kim, J. Ryu, Y.S. Kim Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia J Hosp Infect 52 2002 99 106
    • (2002) J Hosp Infect , vol.52 , pp. 99-106
    • Kim, B.N.1    Woo, J.H.2    Kim, M.N.3    Ryu, J.4    Kim, Y.S.5
  • 23
    • 0036449283 scopus 로고    scopus 로고
    • Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: Risk factors and clinical outcome
    • B. Du, Y. Long, H. Liu Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection Risk factors and clinical outcome Int Care Med 28 2002 1718 1723
    • (2002) Int Care Med , vol.28 , pp. 1718-1723
    • Du, B.1    Long, Y.2    Liu, H.3
  • 24
    • 85007664318 scopus 로고
    • Pharmacokinetics of 6315-S (flomoxef) during blood purification in uremic patients
    • T. Nobuhiro, N. Akira, I. Akio Pharmacokinetics of 6315-S (flomoxef) during blood purification in uremic patients Nippon Kagaku Ryoho Gakkai Zasshi 35 suppl 1 1987 518 522
    • (1987) Nippon Kagaku Ryoho Gakkai Zasshi , vol.35 , Issue.1 , pp. 518-522
    • Nobuhiro, T.1    Akira, N.2    Akio, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.